1. Home
  2. FPH vs OCGN Comparison

FPH vs OCGN Comparison

Compare FPH & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPH
  • OCGN
  • Stock Information
  • Founded
  • FPH 2009
  • OCGN 2013
  • Country
  • FPH United States
  • OCGN United States
  • Employees
  • FPH N/A
  • OCGN N/A
  • Industry
  • FPH Real Estate
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FPH Finance
  • OCGN Health Care
  • Exchange
  • FPH Nasdaq
  • OCGN Nasdaq
  • Market Cap
  • FPH 340.3M
  • OCGN 283.3M
  • IPO Year
  • FPH 2017
  • OCGN N/A
  • Fundamental
  • Price
  • FPH $6.04
  • OCGN $1.07
  • Analyst Decision
  • FPH
  • OCGN Strong Buy
  • Analyst Count
  • FPH 0
  • OCGN 3
  • Target Price
  • FPH N/A
  • OCGN $6.00
  • AVG Volume (30 Days)
  • FPH 158.5K
  • OCGN 7.9M
  • Earning Date
  • FPH 07-21-2025
  • OCGN 08-07-2025
  • Dividend Yield
  • FPH N/A
  • OCGN N/A
  • EPS Growth
  • FPH 69.50
  • OCGN N/A
  • EPS
  • FPH 1.24
  • OCGN N/A
  • Revenue
  • FPH $241,148,000.00
  • OCGN $4,522,000.00
  • Revenue This Year
  • FPH N/A
  • OCGN N/A
  • Revenue Next Year
  • FPH N/A
  • OCGN N/A
  • P/E Ratio
  • FPH $5.03
  • OCGN N/A
  • Revenue Growth
  • FPH 11.66
  • OCGN N/A
  • 52 Week Low
  • FPH $2.88
  • OCGN $0.52
  • 52 Week High
  • FPH $6.71
  • OCGN $1.98
  • Technical
  • Relative Strength Index (RSI)
  • FPH 71.50
  • OCGN 55.30
  • Support Level
  • FPH $5.66
  • OCGN $0.91
  • Resistance Level
  • FPH $6.08
  • OCGN $1.19
  • Average True Range (ATR)
  • FPH 0.21
  • OCGN 0.07
  • MACD
  • FPH 0.06
  • OCGN 0.00
  • Stochastic Oscillator
  • FPH 88.29
  • OCGN 58.19

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: